{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:28:36Z","timestamp":1792985316546,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>Italian Clinical network for FSHD<\/jats:italic>\n                      (ICNF) has established the Italian National Registry for FSHD (INRF), collecting data from patients affected by Facioscapulohumeral dystrophy (FSHD) and their relatives. The INRF has gathered data from molecular analysis, clinical evaluation, anamnestic information, and family history from more than 3500 participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A data management framework, called\n                      <jats:italic>Mediator Environment for Multiple Information Sources<\/jats:italic>\n                      (MOMIS) FSHD Web Platform, has been developed to provide charts, maps and search tools customized for specific needs. Patients\u2019 samples and their clinical information derives from the\n                      <jats:italic>Italian Clinical network for FSHD<\/jats:italic>\n                      (ICNF), a consortium consisting of fourteen neuromuscular clinics distributed across Italy. The tools used to collect, integrate, and visualize clinical, molecular and natural history information about patients affected by FSHD and their relatives are described.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The INRF collected the molecular data regarding FSHD diagnosis conducted on 7197 subjects and identified 3362 individuals carrying a\n                      <jats:italic>D4Z4 Reduced Allele<\/jats:italic>\n                      (DRA): 1634 were unrelated index cases. In 1032 cases the molecular testing has been extended to 3747 relatives, 1728 carrying a DRA. Since 2009 molecular analysis has been accompanied by clinical evaluation based standardized evaluation protocols. In the period 2009\u20132020, 3577 clinical forms have been collected, 2059 follow the Comprehensive Clinical Evaluation form (CCEF). The integration of standardized clinical information and molecular data has made possible to demonstrate the wide phenotypic variability of FSHD. The MOMIS (Mediator Environment for Multiple Information Sources) data integration framework allowed performing genotype\u2013phenotype correlation studies, and generated information of medical importance either for clinical practice or genetic counseling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The platform implemented for the FSHD Registry data collection based on OpenClinica meets the requirement to integrate patient\/disease information, as well as the need to adapt dynamically to security and privacy concerns. Our results indicate that the quality of data collection in a multi-integrated approach is fundamental for clinical and epidemiological research in a rare disease and may have great value in allowing us to redefine diagnostic criteria and disease markers for FSHD. By extending the use of the MOMIS data integration framework to other countries and the longitudinal systematic collection of standardized clinical data will facilitate the understanding of disease natural history and offer valuable inputs towards trial readiness. This approach is of high significance to FSHD medical community and also to rare disease research in general.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-02100-z","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T08:02:37Z","timestamp":1636012957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Italian National Registry for FSHD: an enhanced data integration and an analytics framework towards Smart Health Care and Precision Medicine for a rare disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Cinzia","family":"Bettio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Salsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Calanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Magnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gagliardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3797-1789","authenticated-orcid":false,"given":"Rossella","family":"Tupler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"2100_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1399-0004.2009.01158.x","volume":"75","author":"ML Mostacciuolo","year":"2009","unstructured":"Mostacciuolo ML, Pastorello E, Vazza G, Miorin M, Angelini C, Tomelleri G, et al. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet. 2009;75:550\u20135. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01158.x.","journal-title":"Clin Genet"},{"key":"2100_CR2","unstructured":"Padberg GW. Facioscapulohumeral disease. Faculty of Medicine, Leiden University Medical Center (LUMC), Leiden University; 1982;247. http:\/\/hdl.handle.net\/1887\/25818."},{"key":"2100_CR3","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","volume":"136","author":"G Ricci","year":"2013","unstructured":"Ricci G, Scionti I, Sera F, Govi M, D\u2019Amico R, Frambolli I, et al. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain. 2013;136:3408\u201317. https:\/\/doi.org\/10.1093\/brain\/awt226.","journal-title":"Brain"},{"key":"2100_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0960-8966(91)90094-9","volume":"1","author":"GW Padberg","year":"1991","unstructured":"Padberg GW, Lunt PW, Koch M, Fardeau M. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord Elsevier. 1991;1:231\u20134.","journal-title":"Neuromuscul Disord Elsevier"},{"key":"2100_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ng0992-26","volume":"2","author":"C Wijmenga","year":"1992","unstructured":"Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 1992;2:26\u201330.","journal-title":"Nat Genet"},{"key":"2100_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2169\/internalmedicine.36.333","volume":"36","author":"M Nakagawa","year":"1997","unstructured":"Nakagawa M, Matsuzaki T, Higuchi I, Fukunaga H, Inui T, Nagamitsu S, et al. Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients. Intern Med. 1997;36:333\u20139.","journal-title":"Intern Med"},{"key":"2100_CR7","doi-asserted-by":"publisher","first-page":"12e","DOI":"10.1136\/jmg.2003.008755","volume":"41","author":"K Goto","year":"2004","unstructured":"Goto K, Nishino I, Hayashi YK. Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A. J Med Genet. 2004;41:12e\u201312.","journal-title":"J Med Genet"},{"key":"2100_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nmd.2003.07.001","volume":"14","author":"MMO Tonini","year":"2004","unstructured":"Tonini MMO, Passos-Bueno MR, Cerqueira A, Matioli SR, Pavanello R, Zatz M. Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord. 2004;14:33\u20138.","journal-title":"Neuromuscul Disord"},{"key":"2100_CR9","doi-asserted-by":"publisher","unstructured":"de Greef JC, Lemmers RJLF, van Engelen BGM, Sacconi S, Venance SL, Frants RR, et al. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum Mutat. 2009;30:1449\u201359. https:\/\/doi.org\/10.1002\/humu.21091.","DOI":"10.1002\/humu.21091"},{"key":"2100_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/genes11030258","volume":"11","author":"V Salsi","year":"2020","unstructured":"Salsi V, Magdinier F, Tupler R. Does DNA methylation matter in FSHD? Genes (Basel). 2020;11:258.","journal-title":"Genes (Basel)"},{"key":"2100_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jmedgenet-2011-100454","volume":"49","author":"I Scionti","year":"2012","unstructured":"Scionti I, Fabbri G, Fiorillo C, Ricci G, Greco F, D\u2019Amico R, et al. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. J Med Genet. 2012;49:171\u20138.","journal-title":"J Med Genet"},{"key":"2100_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nmd.2011.11.001","volume":"22","author":"P Sakellariou","year":"2012","unstructured":"Sakellariou P, Kekou K, Fryssira H, Sofocleous C, Manta P, Panousopoulou A, et al. Mutation spectrum and phenotypic manifestation in FSHD Greek patients. Neuromuscul Disord. 2012;22:339\u201349.","journal-title":"Neuromuscul Disord"},{"key":"2100_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2174\/1566524014666141010155054","volume":"14","author":"G Ricci","year":"2014","unstructured":"Ricci G, Zatz M, Tupler R. Facioscapulohumeral muscular dystrophy: more complex than it appears. Curr Mol Med. 2014;14:1052\u201368.","journal-title":"Curr Mol Med"},{"key":"2100_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2015-007798","volume":"6","author":"A Nikolic","year":"2016","unstructured":"Nikolic A, Ricci G, Sera F, Bucci E, Govi M, Mele F, et al. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1\u20133 D4Z4 reduced alleles: experience of the FSHD Italian National Registry. BMJ Open. 2016;6:1\u201310.","journal-title":"BMJ Open"},{"key":"2100_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mus.21671","volume":"42","author":"C Lamperti","year":"2010","unstructured":"Lamperti C, Fabbri G, Vercelli L, D\u2019Amico R, Frusciante R, Bonifazi E, et al. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: the FSHD clinical score. Muscle Nerve. 2010;42:213\u20137.","journal-title":"Muscle Nerve"},{"key":"2100_CR16","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00415-016-8123-2","volume":"263","author":"G Ricci","year":"2016","unstructured":"Ricci G, Ruggiero L, Vercelli L, Sera F, Nikolic A, Govi M, et al. A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes. J Neurol. 2016;263:1204\u201314.","journal-title":"J Neurol"},{"key":"2100_CR17","doi-asserted-by":"publisher","unstructured":"Bergamaschi S, Bouquet P, Giacomuzzi D, Guerra F, Po L, Vincini M. MELIS: an incremental method for the Lexical annotation of domain ontologies. Int J Semant Web Inf Syst. IGI Global; 2007. https:\/\/doi.org\/10.4018\/jswis.2007070103.","DOI":"10.4018\/jswis.2007070103"},{"key":"2100_CR18","unstructured":"Magnotta L, Gagliardelli L, Simonini G, Orsini M, Bergamaschi S. Momis dashboard: A powerful data analytics tool for industry 4.0. Adv Transdiscipl Eng. 2018;7:1074\u201381."},{"key":"2100_CR19","doi-asserted-by":"crossref","unstructured":"Beneventano D, Bergamaschi S, Gagliardelli L, Po L. Open data for improving Youth Policies. In: IC3K 2015 \u2013 proceedings of 7th international jt. conference knowledge discovery and knowledge engineering knowledge management. 2015. www.opendatabarometer.org.","DOI":"10.5220\/0005625401180129"},{"key":"2100_CR20","doi-asserted-by":"publisher","unstructured":"Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L, et al. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet. The American Society of Human Genetics; 2012;90:628\u201335. https:\/\/doi.org\/10.1016\/j.ajhg.2012.02.019.","DOI":"10.1016\/j.ajhg.2012.02.019"},{"key":"2100_CR21","doi-asserted-by":"crossref","unstructured":"Ruggiero L, Mele F, Manganelli F, Bruzzese D, Ricci G, Vercelli L, et al. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy. JAMA Netw open. 2020;3:e204040.","DOI":"10.1001\/jamanetworkopen.2020.4040"},{"key":"2100_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78578-7","volume":"10","author":"G Ricci","year":"2020","unstructured":"Ricci G, Mele F, Govi M, Ruggiero L, Sera F, Vercelli L, et al. Large genotype\u2013phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis. Sci Rep Nat Res. 2020;10:1\u201312. https:\/\/doi.org\/10.1038\/s41598-020-78578-7.","journal-title":"Sci Rep Nat Res"},{"key":"2100_CR23","doi-asserted-by":"publisher","unstructured":"Vercelli L, Mele F, Ruggiero L, Sera F, Tripodi S, Ricci G, et al. A 5-year clinical follow-up study from the Italian National Registry for FSHD. J Neurol. 2021;268:356\u201366. https:\/\/doi.org\/10.1007\/s00415-020-10144-7.","DOI":"10.1007\/s00415-020-10144-7"},{"key":"2100_CR24","doi-asserted-by":"crossref","unstructured":"Nikolic A, Jones TI, Govi M, Mele F, Maranda L, Sera F, et al. Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies. Int J Mol Sci. 2020;21:2635.","DOI":"10.3390\/ijms21072635"},{"key":"2100_CR25","doi-asserted-by":"crossref","unstructured":"Rodolico C, Politano L, Portaro S, Murru S, Boccone L, Sera F, et al. Deletion of the Williams Beuren syndrome critical region unmasks facioscapulohumeral muscular dystrophy. Eur J Paediatr Neurol. 2020;27:25\u20139.","DOI":"10.1016\/j.ejpn.2020.05.006"},{"key":"2100_CR26","unstructured":"Taruscio D, Kodra Y, Ferrari G, Vittozzi L, Annicchiarico G, Attolini E, et al. The Italian National Rare Diseases Registry. Blood Transfus. 2014;12:s606."},{"key":"2100_CR27","doi-asserted-by":"crossref","unstructured":"V H, J L, S M, A R, G J, T B, et al. The Canadian Neuromuscular Disease Registry 2010\u20132019: a decade of facilitating clinical research througha nationwide, pan-neuromusculardisease registry. J Neuromuscul Dis. 2021;8:53\u201361.","DOI":"10.3233\/JND-200538"},{"key":"2100_CR28","doi-asserted-by":"publisher","unstructured":"Guien C, Blandin G, Lahaut P, Sanson B, Nehal K, Rabarimeriarijaona S, et al. The French National Registry of patients with Facioscapulohumeral muscular dystrophy. Orphanet J Rare Dis. 2018;13:1\u201310. https:\/\/doi.org\/10.1186\/s13023-018-0960-x","DOI":"10.1186\/s13023-018-0960-x"},{"key":"2100_CR29","doi-asserted-by":"crossref","unstructured":"H N, M K. [Registry of muscular dystrophy (Remudy). Construction of the patient self-report registry and collaboration with overseas network]. Rinsho Shinkeigaku. Rinsho Shinkeigaku; 2011;51:901\u20132.","DOI":"10.5692\/clinicalneurol.51.901"},{"key":"2100_CR30","doi-asserted-by":"crossref","unstructured":"Stanimirovic D, Murko E, Battelino T, Groselj U. Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia. Orphanet J Rare Dis. 2019;14.","DOI":"10.1186\/s13023-019-1146-x"},{"key":"2100_CR31","doi-asserted-by":"crossref","unstructured":"Alonso V, Abaitua I, Zurriaga \u00d3, Astray J, Errezola M, Aldana-Espinal JM, et al. National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR). Orphanet J Rare Dis. BioMed Central; 2014;9:P5.","DOI":"10.1186\/1750-1172-9-S1-P5"},{"key":"2100_CR32","doi-asserted-by":"crossref","unstructured":"Hamel J, Johnson N, Tawil R, Martens WB, Dilek N, McDermott MP, et al. Patient-reported symptoms in facioscapulohumeral muscular dystrophy (PRISM-FSHD). Neurology. 2019;93:e1180.","DOI":"10.1212\/WNL.0000000000008123"},{"key":"2100_CR33","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archneur.60.10.1421","volume":"60","author":"M Krasnianski","year":"2003","unstructured":"Krasnianski M, Eger K, Neudecker S, Jakubiczka S, Zierz S. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Arch Neurol. 2003;60:1421\u20135.","journal-title":"Arch Neurol"},{"key":"2100_CR34","doi-asserted-by":"crossref","unstructured":"Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H. Where genotype is not predictive of phenotype: Towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum. Genet. 2013. p. 1077\u2013130.","DOI":"10.1007\/s00439-013-1331-2"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02100-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02100-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02100-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T08:12:39Z","timestamp":1636013559000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02100-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2100"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02100-z","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"26 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"470"}}